Keyword: Gates Foundation
An initial analysis showed that J&J's four-strain HIV vaccine elicited a broader immune response than an older trivalent version.
Johnson & Johnson's "mosaic" HIV vaccine regimen elicited immune responses one year after the final shot.
Nonprofit PATH secured a major commitment from the Gates Foundation for its new vaccine group.
In 2008, Charlotte Hubbert was coming to the end of a stem cell and regenerative medicine postdoc at Randall Moon’s laboratory at the University of Washington. She had no plans to get into venture capital. Yet, just six years later, Hubbert found herself not only deeply entrenched in the VC world, but shaping the world’s largest charitable foundation’s move into venture investing.